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Koala retrovirus (KoRV) infection shows differences in prevalence and load between 
northern and southern Australian koala populations; however, the effect of this on diseases 
such as lymphoma and chlamydial disease is unclear.  This study compared 
clinicopathological findings, haematology and splenic lymphoid area of KoRV-positive 
koalas from northern (Queensland [Qld], n = 67) and southern (South Australia [SA], n = 92) 
populations in order to provide further insight into KoRV pathogenesis.  Blood was collected 
for routine haematology and for measurement of KoRV proviral load by quantitative 
polymerase chain reaction (qPCR).   Plasma samples were assessed for KoRV viral load by 
reverse transcriptase qPCR and conjunctival and cloacal swabs were collected for 
measurement of the load of Chlamydia pecorum (qPCR).  During necropsy examination, 
spleen was collected for lymphoid area analysis.  Lymphoma was morphologically similar 
between the populations and occurred in koalas with the highest KoRV proviral and viral 
loads.  Severe ocular chlamydial disease was observed in both populations, but urinary tract 
disease was more severe in Qld, despite similar C. pecorum loads.  No associations between 
KoRV and chlamydial disease severity or load were observed, except in SA where viral load 
correlated positively with chlamydial disease severity.  In both populations, proviral and viral 
loads correlated positively with lymphocyte and metarubricyte counts and correlated 
negatively with erythrocyte and neutrophil counts.  Splenic lymphoid area was correlated 
positively with viral load.  This study has shown further evidence for KoRV-induced 
oncogenesis and highlighted that lymphocytes and splenic lymphoid tissue may be key sites 
for KoRV replication.  However, KoRV infection appears to be highly complex and 
continued investigation is required to fully understand its pathogenesis. 
 




Koala (Phascolarctos cinereus) populations are distributed down the eastern and south-
eastern coast of Australia and are broadly separated into two groups, northern koalas in the 
states of Queensland (Qld) and New South Wales, and southern koalas in South Australia 
(SA) and Victoria (DSEWPC, 2012).  Between the regions, koalas differ in genetics, 
conservation status and disease prevalence.  Recent studies have shown that while koalas 
across Australia are one species, there are different genetic lineages between northern and 
southern regions (Kjeldsen et al., 2016; Neaves et al., 2016).  Additionally, southern koalas 
are less genetically diverse than northern koalas (Neaves et al., 2016), which likely arose 
from historical translocation conservation efforts post-European settlement (Robinson, 1978). 
These translocations may have altered the prevalence of disease in southern populations. 
Oxalate nephrosis is a prevalent disease of southern koalas compared with rare reports in 
northern koalas and is thought to have a genetic basis due to the bottlenecks that occurred as 
a result of the translocations (Speight et al., 2013).  Compared with southern koalas, northern 
populations are recognised as vulnerable to extinction, as these populations are declining at a 
considerable rate, unlike southern populations, where koalas were introduced into previously 
unoccupied areas and are considered overabundant (DSEWPC, 2012).  This is due partly to 
differences in the prevalence of disease between the two regions.  Chlamydia pecorum and 
koala retrovirus (KoRV) are highly prevalent and have been associated with a high 
prevalence of disease in northern populations, while in southern populations there is a lower 
prevalence of infection and disease (Tarlinton et al., 2005; Polkinghorne et al., 2013; Quigley 
et al., 2018a). 
Overt chlamydial disease develops as ocular disease (conjunctivitis and keratitis) 
(Wan et al., 2011), respiratory tract infections (Mackie et al., 2016), urinary tract infections 
(urethritis, cystitis and nephritis) (Canfield, 1989) and reproductive tract disease in females 
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(vaginitis, metritis and paraovarian cysts) (Obendorf, 1981) and males (prostatitis, orchitis 
and epididymitis) (Johnston et al., 2015).  C. pecorum infection may present subclinically, 
with no outward signs of infection or develop into overt disease.  In northern populations, the 
prevalence of C. pecorum infection has been reported to be as high as 90% (Polkinghorne et 
al., 2013), while in southern koalas the prevalence of C. pecorum was lower, up to 46% in 
Victoria (Legione et al., 2016) and 47% in mainland SA (Fabijan et al., 2019a).  Northern 
koalas have also shown a higher prevalence of severe, overt chlamydial disease (Wan et al., 
2011; Polkinghorne et al., 2013), with 52% of hospitalized Qld koalas presenting with 
chlamydiosis (Gonzalez-Astudillo et al., 2017).  In southern koalas, there appears to be a 
lower prevalence of overt disease with reduced disease severity, but in wild-caught Victorian 
koalas, only mild ‘wet-bottom disease’ was observed in 41.6% of koalas and ocular disease 
was not observed (Patterson et al., 2015), and in SA, a low prevalence (21%) of mild ocular 
and urinary tract disease was reported in koalas subjected to necropsy examination (Speight 
et al., 2016).  These differences in prevalence and severity of C. pecorum infection between 
the northern and southern populations suggests that there may be koala population differences 
that facilitate or inhibit chlamydial disease development.  
KoRV, a gammaretrovirus, could be considered the most important pathogen to infect 
koalas due to the oncogenic and immunosuppressive potential of retroviral infections.  In 
northern populations, KoRV-A is 100% prevalent (Chappell et al., 2017; Sarker et al., 2019b) 
and is an active endogenous infection (Greenwood et al., 2017; Hobbs et al., 2017), while 
KoRV-B, which differs to KoRV-A in the env gene (Xu et al., 2013), is presumed to be only 
an exogenous infection (Quigley et al., 2018b).  KoRV-B has been associated with the 
development of lymphoid neoplasia (Xu et al., 2013), which is the most commonly reported 
neoplasia in northern koalas (Canfield, 1990; Gillett, 2014).  KoRV-B has also been 
associated with the development of overt chlamydial disease (Waugh et al., 2017; Quigley et 
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al., 2018a), where KoRV may modulate the immune system and predispose koalas to 
chlamydial disease development from C. pecorum infection.  In southern koalas, KoRV is 
less prevalent, is predominantly KoRV-A infection (Legione et al., 2017; Fabijan et al., 
2019b) and is thought to transmit exogenously (Simmons et al., 2012), which may account 
for the reduced prevalence of chlamydial disease compared with northern koalas. 
This study is part of the Koala Retrovirus Pathogenesis Project, a collaborative study 
which aimed to investigate the differences in disease development between northern (Qld) 
and southern (SA) koala populations based on C. pecorum and KoRV infection status, based 
on proviral DNA loads (KoRV infection burden) and viral RNA loads (KoRV replication 
activity).  Previous studies from this collaboration have reported on KoRV proviral and viral 
loads (Sarker et al., 2019a) and KoRV env variants (Sarker et al., 2019b).  Presented here are 
the detailed clinicopathological findings of these koalas; the current study aimed to compare: 
(1) disease prevalence and severity, (2) haematology values, (3) splenic lymphoid area 
between the populations, and (4) to determine whether disease severity, haematology and 
splenic lymphoid area differed based on KoRV proviral or viral load between the 
populations. 
  
Materials and Methods 
Sample Collection 
Routine necropsy examinations were performed on wild, rescued koalas that had been 
humanely destroyed on welfare grounds between February 2014 and December 2016.  
Thirty-two northern koalas from south-east Brisbane, Qld, were subjected to necropsy 
examination at the School of Veterinary Science, the University of Queensland, Qld, 
Australia, and for comparison, 97 southern koalas from the Mount Lofty Ranges, SA, were 
subjected to necropsy examination at the School of Animal and Veterinary Sciences, the 
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University of Adelaide, SA.  In Qld, an additional 18 wild, rescued koalas were sampled at 
local wildlife hospitals, and 21 koalas from captive populations were sampled during routine 
health examination.  Four SA and four Qld koalas were excluded due to inadequate records 
and one SA koala with oxalate nephrosis was removed as it was the only KoRV-negative 
koala (by polymerase chain reaction [PCR]) in the study.  
Whole blood was collected via the cephalic vein prior to humane destruction or at 
clinical examination into EDTA (Becton Dickinson, New Jersey, New Jersey, USA) for 
haematology, KoRV proviral (DNA) and viral (RNA) loads.  Dry aluminium-shaft cotton 
tipped swabs (Copan Italia, Brasica, Italy) of the left and right conjunctiva (ocular site) and of 
the cloaca of females and urethra of males (urogenital site) were taken for Chlamydia 
pecorum detection by methods previously described (Blanshard and Bodley, 2008).  Age was 
assessed and classified by the amount of wear of the upper premolar (tooth wear class 
[TWC]: I, 1–2 years; II, 2–3 years; III, 4 years; IV, 5–6 years; V, 8–9 years; VI, 12+ years) 
(Martin and Handasyde, 1999) or from captive records.  Body condition score was assessed 
by the degree of musculature of the scapula (Blanshard and Bodley, 2008).  Tissue samples 
were collected into 10% neutral buffered formalin for histopathological examination. This 
research was approved by the animal ethics and state government research permits issued by 
the University of Adelaide Animal Ethics Committee S-2013-198, the University of 
Queensland Animal Ethics Committee, ANFRA/SVS/461/12 and ANRFA/SVS/445/15, the 
South Australian Government Department of Environment, Water and Natural Resources 
Scientific Research Permit Y26054 and the Queensland Government Department of 





When fresh blood was available, routine haematology was performed using a Cell-Dyn 3700 
automated haematology analyser (Abbott Diagnostics Division, Santa Clara, California, 
USA).  Blood parameters determined by the analyser included erythrocyte (RBC) count, 
haemoglobin (Hb) concentration, haematocrit (HCT), mean corpuscular volume (MCV), 
mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration 
(MCHC) and leucocyte (white blood cell [WBC]) count.  Blood smears were reviewed to 
perform manual leucocyte differential counts and estimate nucleated RBCs (nRBCs) per 100 
WBCs.  For nRBC counts >5 per 100 WBCs, the analyser WBC count was corrected and 
absolute nRBC count determined.  Blood smears were also used to perform manual platelet 
counts.  Packed cell volume (PCV) was determined following centrifugation of 
microhaematocrit tubes at 5,000 rpm for 5 min.  Haematological results were assessed against 
population specific reference intervals, where Qld koalas were assessed against established 
reference intervals in northern populations (Canfield et al., 1989b) and SA koalas were 
assessed against southern koala reference intervals (Fabijan et al., 2020). 
 
Histopathology, Immunohistochemistry and Disease Category 
Lymph nodes (submandibular, axillary, inguinal and mesenteric), spleen, liver, kidney, 
bladder and reproductive organs, where available, were processed routinely for 
histopathological examination.  Sections (4 µm) were stained with haematoxylin and eosin 
(HE).  Lymph nodes affected by lymphoid neoplasia were subjected to 
immunohistochemistry (IHC) with markers for T- and B-lymphocytes at the Koala Health 
Hub, University of Sydney, Sydney, NSW, as described previously (Connolly et al., 1998). 
Lymph nodes were labelled with the T-cell marker CD3 (polyclonal rabbit anti-human, Dako, 
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Glostrup, Denmark) and the B-cell marker CD79b (monoclonal mouse anti-human, Dako) 
and appropriate horseradish peroxidase-conjugated secondary reagents.  Labelling was 
‘visualized’ using 3, 3’-diaminobenzidine as a chromogen.  Healthy koala and human lymph 
node sections were used as controls. The primary antibody was omitted for negative control 
tissues.   
Koalas were classified into four disease categories based on their primary disease 
finding: neoplasia, chlamydial disease, miscellaneous diseases (including, but not limited to, 
oxalate nephrosis, cardiovascular, respiratory and gastrointestinal tract diseases) and disease-
free (including clinically healthy captive koalas and koalas humanely destroyed due to 
vehicle trauma, predation or musculoskeletal abnormalities such as scoliosis and kyphosis, 
but with no other abnormalities). 
 
Splenic Lymphoid Area Analysis 
One randomly selected section of spleen from 10 Qld and 31 SA koalas was examined 
histologically to compare lymphoid follicle and periarteriolar lymphoid sheath (PALS) size in 
order to assess changes due to antigenic stimulation or lymphoid depletion (Woolford et al., 
2015).  Splenic morphology was compared between koalas with chlamydial disease (Qld, n = 
8; SA, n = 15), miscellaneous diseases (Qld, n = 2; SA, n = 5) and disease-free koalas (SA, n 
= 11).   The area of each follicle and PALS were measured using the area tool (m2) using 
LabSensTM software (  ).  The mean lymphoid area (mean of total follicle and PALSs) 




C. pecorum Detection by Quantitative Polymerase Chain Reaction and Chlamydial Disease 
Classification 
Assessment of C. pecorum positivity (all genotypes) and load (copies/μl) was outsourced to 
the University of the Sunshine Coast, Qld, Australia (Marsh et al., 2011).  Briefly, C. 
pecorum DNA was detected from swabs collected from the ocular and urogenital sites by 
quantitative (q) PCR.  DNA was extracted from each swab using a Qiagen DNA Mini kit 
(Qiagen, Hilden, Germany) and stored at –80oC.  Detection of C. pecorum was performed 
using qPCR (Marsh et al., 2011).  
Overt ocular and urinary tract diseases were graded on a three-point scale (1, mild; 2, 
moderate; 3, severe) as described previously (Wan et al., 2011).  Briefly, ocular disease was 
observed as: grade 1, acute conjunctival inflammation; grade 2, chronic conjunctival 
hyperplasia; and grade 3, chronic, active conjunctivitis with exudation.  Urinary disease was 
observed as: grade 1, mild cystitis (acute/subacute infection including histologically detected 
only) or cloacal discharge; grade 2, chronic inactive cystitis and/or paraovarian cysts; and 
grade 3, chronic active cystitis + nephritis, and/or active reproductive tract infection (Wan et 
al., 2011). 
  
Koala Retrovirus Detection and Viral Load Quantification 
The PCR protocols and results have been previously reported (Sarker et al., 2019a). Briefly, 
KoRV DNA was detected and proviral load determined from whole blood using qPCR. 
Plasma collected into RNALaterTM (Qiagen), was used to determine the KoRV RNA viral 
load using a two-step reverse transcription qPCR.  Both the proviral and viral qPCR protocols 
utilized primers that amplified a portion of the pol gene conserved to all KoRV env variants 




Multivariate logistic regression analysis for the Koala Retrovirus Pathogenesis Project has 
been reported previously (Sarker et al., 2019a). The present study compared Qld and SA 
koalas based on haematological parameters, splenic lymphoid area, chlamydial loads and 
KoRV loads and associated clinicopathological findings.  For statistical analysis, SPSS 
version 24 ( ) was utilised.  Normality was determined for the continuous variables; KoRV 
proviral loads, KoRV viral loads, chlamydial loads, haematological parameters and splenic 
lymphoid area by the Shapiro–Wilk test. KoRV proviral load, KoRV viral loads, chlamydial 
load, splenic lymphoid area, eosinophil count and basophil count were not normally 
distributed and were compared using non-parametric Mann–Whitney or Kruskal–Wallis tests. 
All other haematological parameters were normally distributed and were compared using a 
univariate GLM with type III sums of squares modelled with population, disease category 
and population nested within disease category.  Binomial explanatory variables included 
population (Qld or SA) and sex (female or male).  Ordinal explanatory variables including 
disease category (neoplasia, chlamydial disease, miscellaneous disease and disease-free), 
KoRV group (based on log transformation of viral load: none, low and high), chlamydial 
disease severity (mild, moderate and severe), age group (young, TWC I and II; adult, TWC 
III and IV; senior, TWC V and VI), BCS (poor, BCS 1 and 2; fair, BCS 3; excellent, BCS 4 
and 5).  A Chi-squared test of proportions was used to compare between binomial and ordinal 
variables.  In order to determine if any correlations existed between continuous variables, a 
Spearman’s rho (ρ) correlation coefficient and statistical significance was determined if 





Clinical and Pathological Findings  
Details of all of the koalas are given in Table 1.  Neoplasia was detected in 13.4% of 
Qld koalas (9/67) and 5.4% of SA koalas (5/92).  In Qld, five koalas presented with lymphoid 
neoplasia (7.5%, two with lymphoma and three with lymphoid leukaemia), one with 
mesothelioma (1.5%) and three with osteochondroma (4.5%; two craniofacial and one 
costal).  In SA, four koalas presented with lymphoma (4.3%) and one with craniofacial 
osteochondroma (1.1%).  
Both Qld and three SA koalas with lymphoma affecting lymph nodes, thymus and 
spleen also had involvement of non-lymphoid bone marrow, gastrointestinal tract, liver, 
pancreas, heart, lungs, kidney, bladder (Fig. 1), adrenal gland and/or brain.  A single young 
male koala from SA presented with lymph node involvement only.  Neoplastic lymphocytes 
were characterized as intermediate to large round cells with minimal cytoplasm with up to a 
four-fold anisocytosis and anisokaryosis.  Nuclei were round to oval with coarsely granular 
chromatin, with single to several nucleoli.  In the SA koalas with lymphoma, the median 
mitotic rate was 4 (range 2–15) mitotic figures per 10 ×400 high-power fields (HPFs), but 
mitotic rate was not evaluated in the affected Qld koalas.  One Qld koala and two SA koalas 
had B-cell lymphoma of the lymph node as determined by IHC (Fig. 2), while phenotype for 
the remaining tumours was undetermined. 
Chlamydial disease was observed in 46.3% (31/67) of Qld and 35.9% (33/92) of SA 
koalas. In Qld, nine koalas (29.0%) presented with C. pecorum disease confirmed by PCR, 16 
(51.6%) with Chlamydia-like disease (PCR negative) and six (19.4%) with Chlamydia-like 
disease with unknown C. pecorum status, as they were not tested for C. pecorum. In SA, 15 
koalas (16.3%) presented with C. pecorum disease confirmed by PCR, 14 (15.2%) presented 
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with Chlamydia-like disease (PCR negative) and four (4.3%) with Chlamydia-like disease 
with unknown C. pecorum status.  
Conjunctivitis, pneumonia, urinary and reproductive tract disease was observed in 
both females and males.  Chlamydial disease was observed at one site only in 61.3% (19/31) 
of Qld and 54.5% (18/33) of SA koalas and the remaining koalas had disease at two or more 
sites (Table 2).  In Qld, all cases of chlamydial disease were identified during necropsy or 
clinical examinations.  In SA, 70% (35/50) of chlamydial disease was identified as gross 
lesions during necropsy examination (75% of ocular disease cases [3/4], 74% of urinary tract 
disease [17/23] and 65% of reproductive tract disease [15/23]); the remaining 30% of lesions 
(15/50) were detected during histological examination. 
Grossly apparent ocular lesions (Fig. 3) were observed in both populations from grade 
1 to 3 in severity (Table 3).  The mean ocular chlamydial load of Qld koalas with confirmed 
chlamydial ocular disease (n = 2) was 1,105 copies/μl (range 796–1,413) and in SA (n = 3) 
was only 30 copies/μl (range 30–100).  Qld koalas were significantly more likely to present 
with ocular disease than SA koalas (P <0.001) and had significantly higher ocular chlamydial 
load (P <0.001).  There was no difference in chlamydial disease severity between the 
populations in the proportion of koalas (P = 0.894) or chlamydial load (P = 0.076) for those 
with severe ocular disease.  
Qld koalas were significantly more likely to present with grade 3 urinary tract disease, 
while SA koalas were more likely to present with grade 1 disease (P <0.001) (Fig. 4).  No SA 
koalas were observed with grade 3 urinary tract disease (Table 3).  The mean urogenital 
chlamydial load of Qld koalas (n = 4) was 1,224 copies/μl (range 290–19,127) and in SA (n = 
9) was 1,660 copies/μl (range 35–320,000).  There was no difference in the occurrence of 
urinary tract disease between the populations (P = 0.479) or the urogenital load of C. 
pecorum positive koalas (P = 0.903). 
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Reproductive tract disease was observed in both female and male koalas from SA, 
while in Qld disease was only recorded as being present in four female koalas at necropsy 
examination. The prevalence is difficult to compare between the two populations as the 
reproductive tracts of the other Qld koalas were not available for histological examination 
(Table 3).  The SA koalas with reproductive tract disease only were predominantly female 
(8/9), and of all the female koalas with reproductive tract disease (n = 13), six had concurrent 
endometritis and paraovarian cysts.  Most lesions in females were seen grossly at necropsy 
examination (11/13).  Reproductive tract disease in male koalas (n = 10) was mild in nature, 
and orchitis and epididymitis were not observed.  
Comorbidities with chlamydial disease were observed commonly.  Miscellaneous 
comorbidities (including trauma, scoliosis and kyphosis, renal, cardiac and respiratory 
disease) were observed in 12 Qld and 16 SA koalas. Koalas with neoplasia were also often 
seen with concurrent chlamydial disease, including five Qld and two SA koalas.  
Subclinical chlamydial infection (no associated lesions) was identified at the ocular 
and urogenital sites in both Qld and SA koalas. The median ocular chlamydial load of Qld 
koalas with subclinical C. pecorum ocular infection (n = 4) was 270 copies/μl (range 120–
32,942) and in SA (n = 5) was 1,500 copies/μl (range 513–7,469). The urogenital load of the 
single Qld koala with subclinical urogenital infection was 793 copies/μl, and the urogenital 
chlamydial load of SA koalas with subclinical urogenital infection (n = 6) was 1,725 
copies/μl (range 180–19,400).  
Miscellaneous diseases were recorded in 6.0% (4/67) of Qld and 33.7% (31/92) of SA 
koalas.  Miscellaneous diseases observed in Qld koalas included respiratory disease (1.5%, 
1/67), hepatic disease (1.5%, 1/67) and poor condition (3.0%, 2/67).  No cases of oxalate 
nephrosis were observed in Qld.  In SA, miscellaneous diseases included oxalate nephrosis 
(18.5%, 17/92), infected traumatic injuries (5.4%, 5/92), respiratory disease (3.2%, 3/92), 
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gastric torsion (2.2%, 2/92), thromboembolic disease (1.1%, 1/92) and no significant findings 
at necropsy examination (4.4%, 4/92).  
 
Haematology and Disease Category 
Koalas with neoplasia (SA and Qld combined) had significantly lower RBC, Hb, PCV, WBC, 
neutrophil and lymphocyte counts, and the highest nRBC counts compared with the other 
disease categories (Fig. 5).  All koalas with neoplasia had severe anaemia (normocytic and 
normochromic non-regenerative anaemia based on red cell indices, as reticulocyte counts 
were not performed).  Most WBC indices were below reference intervals; three animals had 
moderate leucopenia and neutropenia, and one koala had moderate neutropenia and 
lymphocytosis. There were no differences in haematological values between koalas from Qld 
and SA with neoplasia. 
Koalas with chlamydial disease had lower Hb and monocyte counts and higher WBC 
and neutrophil counts than the other disease categories (Fig. 5).  Koalas with ocular 
chlamydial disease had elevated nRBC counts compared with koalas with urinary tract and 
reproductive tract disease (P = 0.006).  Koalas with urinary tract disease had haematological 
parameters that were within reference intervals.  Koalas with reproductive tract infections 
were significantly more likely to present with leucocytosis than koalas with ocular and 
urinary tract diseases (P = 0.011) and neutrophilia was commonly observed but was not 
significant overall (P = 0.068).  The only parameter that differed between Qld and SA koalas 
with chlamydial disease was a higher nRBC count in the former group (P = 0.002). 
Koalas with miscellaneous diseases had significantly higher PCVs and monocyte 
counts and low neutrophil counts, while disease-free koalas had the highest Hb, PCV, WBC 
and lymphocyte counts and the lowest nRBC and monocyte counts (Fig. 5).  
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Splenic Lymphoid Area and Disease Category 
Splenic morphological examination in koalas from both populations with lymphoid neoplasia 
showed mild to severe lymphoproliferation and/or neoplastic transformation, without defined 
follicles or PALSs.  Qld and SA koalas with chlamydial disease showed lymphoid atrophy (n 
= 2), mild lymphoid hyperplasia (n = 2) or non-specific findings (NSF) (n = 19). All koalas 
with miscellaneous diseases had NSFs (n = 7). The disease-free SA koalas showed 
congestion (n = 6), contraction (n = 1) or NSFs (n = 2).  No splenic tissue samples were 
available for disease-free Qld koalas. 
A higher number of PALSs than follicles were observed per section of spleen 
examined at random.  When disease categories were compared (with populations combined), 
the median number of PALSs within a mean spleen section of 2.45 × 107 (± SD 1.60 × 107) 
m2, was significantly higher in koalas with chlamydial disease compared with 
miscellaneous diseases (P = 0.002).  Qld koalas with chlamydial disease had significantly (P 
= 0.045) larger median PALSs at 129,227 μm2 (range 40,466–530,077) than SA koalas, 
57,564 μm2 (range 18,201–230,588).  
 
Koala Retrovirus Status 
KoRV loads for koalas within the Koala Retrovirus Pathogenesis Project have been reported 
separately (Sarker et al., 2019a).  A multivariate logistic regression analysis showed that Qld 
koalas had overall higher KoRV proviral and viral loads compared with SA koalas, and that 
koalas with neoplasia had significantly higher proviral and viral loads than koalas from the 
other disease categories.  Additionally, all KoRV genes (LTR, gag, pol and env) were 
detected at the proviral and viral level in all Qld koalas, but only five (5.4%) SA koalas were 
positive for all proviral and viral genes (Sarker et al., 2019a).  
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Of the koalas in this study, the median KoRV proviral load of the Qld koalas (n = 67) 
was 5.40 × 104 copies/103 β-actin copies (range 1.04 × 104–5.90 × 105) and in SA (n = 92) 
was 2.67 × 103 copies/103 β-actin copies (range 10.6–4.32x105).  All Qld koalas had KoRV 
viraemia, where the median KoRV viral load was 4.03 × 108 copies/ml of plasma (7.76 × 
106–7.58 × 1011); however, only 52.6% of the SA koalas (20/38) were KoRV viraemic; the 
viral loads of active KoRV infections in SA was 2.22 × 105 copies/ml of plasma (2.28 × 104–
4.34 × 1010).  
 
Comparison of Koala Retrovirus Between Queensland and South Australian Koalas Within 
Each Disease Category 
To further investigate the role of KoRV infection in Qld and SA koalas, KoRV proviral and 
viral loads were compared between Qld and SA koalas within each disease category (Table 
5).  Proviral load (P = 0.947) and viral load (P = 0.758) were similar between Qld and SA 
koalas with neoplasia, while Qld koalas in the chlamydial disease, miscellaneous disease and 
disease-free categories all had significantly higher proviral and viral loads than the SA koalas 
in the same groups (P <0.01).  
All koalas were grouped into three KoRV activity groups based on the log 
transformed KoRV viral load; high KoRV activity (log10 viral load >6.5), low KoRV activity 
(log10 viral load <6.5) and no KoRV activity (viraemia negative) (Fig. 6).  All Qld koalas 
were in the high KoRV activity group; the low KoRV and no KoRV activity groups consisted 
of SA koalas only.  Of the SA koalas in the high KoRV activity group, three had neoplasia, 
one had chlamydial disease and one had a miscellaneous disease; there were no disease-free 
koalas in the high KoRV group.  In SA, koalas with neoplasia were significantly more likely 
to be in the high KoRV activity group (P = 0.013) than koalas without neoplasia.  Only one 
koala with neoplasia (osteochondroma) fell into the low KoRV activity group, while all 
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koalas with lymphoma were in the high KoRV activity group.  KoRV proviral load was 
significantly different between all three KoRV activity groups (P = 0.001), while the median 
proviral load increased with increasing KoRV activity.  The median proviral loads of SA 
koalas with no, low and high KoRV activity were 1.55 × 103 copies/103 β-actin copies (range 
1.11 × 102–1.65 × 104), 6.35 × 103 copies/103 β-actin copies (range 5.29 ×  102–5.05 × 104) 
and 2.14 × 105 copies/103 β-actin copies (range 6.26 × 103–4.32 × 105).  
 
Koala Retrovirus and Chlamydial Disease 
There was no correlation between chlamydial disease severity and proviral and viral loads for 
Qld koalas (P = 0.060 and P = 0.850, respectively) or proviral load in SA (P = 0.401); 
however, in SA there was a positive correlation between increasing chlamydial disease 
severity and increasing KoRV viral load (ρ = 0.745; P = 0.031).  In SA, there were no 
differences between chlamydial disease severity and KoRV groups (high, low, no) (P = 
0.390).  There was no correlation between ocular or urogenital chlamydial loads and KoRV 
proviral or viral loads in Qld (P >0.1) or SA koalas (P >0.05). 
 
Koala Retrovirus and Haematology 
Significant, negative correlations were observed between proviral load and RBC (ρ= -0.297; 
P = 0.003), PCV (ρ = -0.257; P = 0.012) and neutrophil counts (ρ = -0.331; P = 0.001), and 
positive correlations were observed with absolute nRBCs (ρ = 0.264; P = 0.014) and 
lymphocyte counts (ρ = 0.239; P = 0.018).  Significant, negative correlations were also 
observed between viral load and RBC (ρ = -0.279; P = 0.018) and neutrophil counts (ρ = -
0.280; P = 0.018), and positive correlations were observed with absolute nRBC (ρ = 0.318; P 
= 0.012) and lymphocyte counts (ρ = 0.301; P = 0.011).  Koalas in the high KoRV activity 
group had significantly (P = 0.001) higher median lymphocyte counts (2.76 × 109/l ; range 
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0.05–5.94) than koalas in the low KoRV activity group (1.04 × 109/l; range 0.41–5.10) and in 
the no KoRV activity group (0.79 × 109/l; range 0.26–3.82). 
 
Koala Retrovirus and Splenic Lymphoid Area 
There were no significant correlations between number of follicles or PALSs and proviral 
and viral load (P >0.2) or for follicle size (P >0.1).  There was no correlation between PALS 
size and proviral load (P = 0.213); however, there was a positive correlation between PALS 
size and increasing viral load (ρ = 0.438; P = 0.025).  Koalas with no follicles were 
significantly more likely to be in the high KoRV activity group than koalas with follicles (P = 




This study compared the pathological findings of KoRV-positive northern (Qld) and southern 
(SA) koalas in order to determine whether differences in disease prevalence and severity, 
haematology and splenic lymphoid area occurred, and whether these were affected by KoRV 
proviral and viral loads.  Koalas were grouped into four disease categories: neoplasia, 
chlamydial disease, miscellaneous disease and disease-free, based on the known association 
of KoRV with lymphoid neoplasia and the proposed link of KoRV to chlamydial disease 
(Tarlinton et al., 2005).  Key findings were: (1) SA koalas developed lymphoma with similar 
gross, histopathological and immunophenotypic presentations as Qld koalas and, in both 
populations, lymphoma only occurred in koalas with high KoRV loads, (2) severe ocular 
chlamydial disease was observed in both populations, but was less prevalent in SA and in SA 
clinical disease was only seen in koalas with high KoRV viral loads, (3) urogenital tract 
chlamydial disease was common in both populations, but  was less severe in SA koalas 
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despite similar urogenital chlamydial loads, (4) no association was found between KoRV 
proviral and viral loads and chlamydial disease severity, and (5) correlation between KoRV 
loads and peripheral blood lymphocyte count and splenic lymphoid area suggested that 
lymphocytes may be key sites for KoRV viral replication.  
Lymphoid neoplasia was the most common neoplasm observed in koalas from both 
Qld and SA populations.  There were a number of similarities in lymphoma observed 
between Qld and SA koalas; all neoplastic cells had the same morphological appearance, 
being intermediate to large neoplastic cells, and B-cells were identified as the neoplastic cell 
of origin in both populations, which is similar to other cases of lymphoma described in 
northern koalas (Connolly et al., 1998; Spencer and Canfield, 1996).  All koalas also had 
multiple organ involvement except for one young, 1- to 2-year-old (TWC I) male SA koala 
where lymphoma was detected only in lymph nodes.  Lymphoid neoplasia has been well 
described in northern koalas since the first reports in 1961 (Backhouse and Bolliger, 1961; 
Heuschele and Hayes, 1961; Spencer and Canfield, 1996; Connolly et al., 1998).  The 
prevalence of lymphoid neoplasia in Qld (7.5%) was similar to findings in other studies in 
northern koalas, such as a study of wild koalas from New South Wales that reported 
neoplasia in 7% (11/162) of koalas, and lymphoma was the most common tumour (Canfield, 
1990).  In contrast, lymphoma was only reported recently in a single SA female koala 
(Fabijan et al., 2017), with no previous reports in wild, rescued SA koalas (Speight et al., 
2018) or captive southern koalas from Victoria or SA (Gillett, 2014).  In addition to the 
histopathological similarities, these koalas also had the highest KoRV proviral and viral loads 
(Sarker et al., 2019a).  This was consistent with a previous study of northern koalas where 
koalas with lymphoid neoplasia had the highest KoRV proviral and viral loads (Tarlinton et 
al., 2005).  Notably, the SA koalas with neoplasia had proviral and viral loads at the same 
high level as the Qld koalas with neoplasia, which were significantly higher than all other SA 
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koalas.  The increased prevalence of lymphoid neoplasia in SA koalas may reflect a possible 
increase in the prevalence of KoRV within the population.  Recently, the prevalence of 
KoRV in the SA Kangaroo Island population was shown to have increased from 15% in 2012 
(Simmons et al., 2012) to 43% in 2017 (Fabijan et al., 2019b).  The KoRV env variant 
infections of the koalas in this study have been previously reported (Sarker et al., 2019b), and 
no association between KoRV variant infections and neoplasia was found. The findings of the 
current study may then suggest that total KoRV burden, rather than KoRV variants, may be 
more important in the development of lymphoma. 
Osteochondroma was the second most common tumour observed, which was 
similarly reported in a study of koalas from New South Wales (Canfield, 1990).  This is also 
the first report of this tumour affecting SA koalas.  It is unknown whether KoRV plays a role 
in the development of osteochondroma.  In this study, Qld koalas with osteochondroma had 
high proviral and viral loads, while the single SA koala had a high proviral load and low viral 
load.  Previous studies have also hypothesized the role of KoRV in the development of 
osteochondroma in the koala (Hanger and Loader, 2014) as this tumour is known to develop 
in association with feline leukaemia virus (FeLV) infection in cats (Hartmann, 2012). 
Differences in chlamydial disease severity were observed between Qld and SA koalas, 
despite some limitations in comparing disease.  Ocular disease was more prevalent in Qld 
(58.1%) koalas compared with animals from SA (12.1%), but severe cases were observed in 
both locations with comparable chlamydial loads.  A low prevalence of mild ocular disease 
has been previously reported in SA koalas (Speight et al., 2016), despite the first reports of 
chlamydiosis in SA describing three koalas with severe conjunctivitis (Funnell et al., 2013). 
The prevalence of urinary tract disease and the urogenital chlamydial load of koalas with 
disease were similar between the populations; however, the urinary tract disease observed in 
SA koalas had reduced severity.  As the reproductive tracts of the Qld koalas were not 
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available for examination, comparison of chlamydial reproductive tract disease between the 
populations was limited.  This study found a higher prevalence of reproductive tract disease 
in SA koalas than a previously necropsy study that reported mild reproductive lesions in 
9.2% (6/65) of koalas (Speight et al., 2016). These differences in disease severity may be due 
to chlamydial factors, such as different C. pecorum genotypes present within the populations 
(Kollipara et al., 2013) and the absence of the chlamydial plasmid, pCpec, in SA isolates 
(Jelocnik et al., 2015) which may carry virulence factors (Phillips et al., 2018). Koala factors 
may also account for the disease differences, as northern and southern koalas fall into 
separate genetic lineages (Kjeldsen et al., 2016), and there may be variation in koala 
immunity that results in different disease severity (Mathew et al., 2014).  
Compared with previous studies of C. pecorum prevalence in SA and Qld, there was a 
low PCR detection rate of C. pecorum, similar to other studies of chlamydial disease in Qld 
and Victorian koalas that reported a low detection rate of C. pecorum where not all koalas 
with chlamydial disease were C. pecorum positive (Wan et al., 2011; Patterson et al., 2015; 
Legione et al., 2016; Nyari et al., 2017).  Koalas with chlamydial disease that were C. 
pecorum-negative may cease shedding of the bacteria where the disease has not resolved 
(Nyari et al., 2017). The koalas with Chlamydia-like disease may also have been infected 
with C. pneumoniae; however, based on previous studies that showed C. pecorum to be a 
more common and virulent pathogen (Polkinghorne et al., 2013), C. pneumoniae was not 
tested in the present study.  
It has been hypothesized that KoRV may cause immune suppression, predisposing 
koalas to developing chlamydial disease. This theory was thought to explain the differences 
in chlamydial disease observed between northern and southern koalas, where southern koalas 
may have a lower KoRV prevalence and resulting lower prevalence of chlamydial disease. 
Recent studies in northern koala populations found an association between KoRV-B infection 
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and chlamydial disease (Waugh et al., 2017; Quigley et al., 2018a) and in Victorian koalas 
KoRV infection was associated with wet-bottom disease (Legione et al., 2017). In this 
collaborative study, no clear association was observed between KoRV proviral load, viral 
load or variant type and chlamydial disease in either population (Sarker et al., 2019a, b), 
although a strong, positive correlation between increasing chlamydial disease severity and 
increasing KoRV viral load was found in SA koalas.  As the development of chlamydial 
disease is likely to be highly complex, studies with larger numbers of koalas may find clear 
associations between KoRV and chlamydial disease severity, particularly in SA. 
Comparison of haematological variables between the four disease categories has 
highlighted some key diagnostic indicators for disease. In both populations, non-regenerative 
anaemia and inappropriate metarubricytosis were strongly associated with neoplasia, while 
neutrophilia was most commonly observed in koalas with chlamydial disease. Previous 
haematological studies have found similar indicators of these diseases in northern koalas 
(Obendorf, 1983; Canfield et al., 1989a); however, this has not been reported previously for 
southern koalas, in which lymphoid neoplasia and chlamydial disease are being observed 
more frequently.  
Splenic lymphoid area analysis suggested lymphoid hyperplasia in koalas with 
chlamydial disease. While there were considerably more PALSs than follicles for all koalas, 
PALSs were significantly more numerous in koalas with chlamydial disease. A higher 
number of PALSs than follicles has been reported previously in the koala (Backhouse and 
Bolliger, 1961; Hemsley, 1996) and IHC was used to demonstrate that large populations of T-
cells reside in the PALS and B-cells in follicles (Hemsley, 1996).  If PALSs are more 
common in chlamydial infection, this may suggest increased cell-mediated immunity in these 
koalas; cytotoxic T cells in particular are key in the immune response to intracellular 
pathogens in other species (Clerici and Shearer, 1993). 
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Comparison of haematology and splenic lymphoid area with KoRV proviral and viral 
loads highlighted that lymphocytes may be a key site of KoRV replication. In the current 
study, increased lymphocyte counts (lymphocytosis), anaemia (non-regenerative normocytic 
normochromic), and increasing inappropriate metarubricytosis were all correlated with 
increasing KoRV proviral and viral loads. Additionally, splenic lymphoid area was correlated 
positively with KoRV viral load. These findings in koalas may mirror retroviral infections in 
other species, where retroviral infection of haemopoietic stem cells can disrupt haemopoietic 
stem cell differentiation (Hartmann, 2012).  Lymphocytosis may arise in response to 
retroviral infection such as in people with human immunodeficiency virus infection (Mellors 
et al., 1997) and cats with feline immunodeficiency virus (FIV) infection (Powers et al., 
2018).  Mild to severe normocytic normochromic anaemia and inappropriate rubricytosis in 
cats is associated with FeLV infection (Stockham and Scott, 2008; Gleich and Hartmann, 
2009) and inappropriate metarubricytosis may also occur in domestic species with viral 
infection (Stockham and Scott, 2008).  However, it should be noted that lymphocytosis, non-
regenerative anaemia and inappropriate metarubricytosis may also occur under other 
circumstances, such as with bone marrow injury, altered splenic function, heat stroke and 
dyserythropoiesis and for unknown reasons (Stockham and Scott, 2008).  Future studies 
should investigate the role of lymphocytes, bone marrow, spleen, lymph nodes and other 
lymphoid tissues in KoRV infection and replication, and the implications of this on koala 
health. 
Qld koalas had high levels of KoRV viral activity, while the SA koalas were more 
variable, falling into one of three distinct groups based on KoRV viral load: koalas with high, 
low and no KoRV activity. There are two possible hypotheses that may explain these 
population differences in KoRV viral activity: (1) KoRV is an exogenous infection in SA 
koalas which is being suppressed by the koala’s immune response, or (2) SA koalas have 
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defective KoRV proviral inserts that do not produce KoRV viral particles.  The differences in 
KoRV activity in SA koalas is reminiscent of exogenous FeLV infections in domestic cats 
(Hartmann et al., 2012). The cat’s initial immune response to FeLV dictates disease 
progression; cats that mount a rapid immune response develop latent FeLV infections and 
may be asymptomatic, while a delayed or deficient immune response leads to progressive 
infections observed as persistent high FeLV viraemia and neoplasia development (Hartmann, 
2012).  If KoRV is transmitted exogenously between SA koalas, koalas with no or low KoRV 
activity may have mounted sufficient immune responses to suppress KoRV replication and 
harbour latent infections, while koalas with high KoRV activity may have progressive 
infections and be at higher risk of developing lymphoid neoplasia, as was observed in this 
study.  The koala’s immune response to KoRV infection has only recently been investigated 
and studies are yet to show clear immune responses to KoRV infection (Maher and Higgins, 
2016; Waugh et al., 2016; Olagoke et al., 2018, 2019;  Maher et al., 2019).  
Alternatively, SA koalas with no or low KoRV activity may have truncated or 
defective proviral inserts that are not transcribed to make virus particles. Evidence for this 
has been observed as part of this collaborative project. Transcriptomic analysis of 
submandibular lymph nodes from Qld (n = 10) and SA (n = 19) koalas showed that all genes 
of KoRV-A, KoRV-B and other env variants are highly expressed in Qld koalas, while in SA 
only the LTR and partial gag gene were expressed in all koalas, and the expression of the pol 
and env genes were significantly reduced in 14 koalas and no expression was detected in five 
koalas (Tarlinton et al., 2017).  The low level or lack of expression of the pol and env genes 
occurred at the same RNA base pairs for all koalas, which suggests that transcription of the 
provirus is inhibited at this site and that the provirus may be truncated (Tarlinton et al., 
2017).  The KoRV pathogenesis project further investigated the possibility of truncated 
proviruses in SA koalas and showed all Qld koalas possessed all KoRV genes (LTR, gag, pol 
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and env), but only 79% (77/97) of SA koalas were positive for all proviral genes (Sarker et 
al., 2019a).  Further investigation is required to understand the differences in KoRV infection 
between Qld and SA koalas, to understand if KoRV is exogenously transmitted or if KoRV is 
a defunct, endogenous retrovirus in some SA koalas.  
The finding that SA koalas develop lymphoma with the same neoplastic morphology, 
site predilections and high KoRV loads as Qld koalas, suggests similar oncogenic 
mechanisms of KoRV may be occurring in both populations. The high proviral load in these 
koalas may support the idea of lymphoma developing via insertional mutagenesis (Tarlinton 
et al., 2005) or via upregulation of adjacent genes (Xu et al., 2013).  KoRV variants may also 
be involved.  A previous study showed that KoRV-B infection, thought to be exogenously 
transmitted, was associated with the development of lymphoid neoplasia in captive northern 
koalas (Xu et al., 2013).  In the current collaborative project, no clear associations between 
neoplasia and KoRV variants were observed (Sarker et al., 2019b); however, this study was 
based on a small number of koalas from SA and further investigation with more koalas may 
shed more light on the role of KoRV variants and disease development. While continued 
investigation is required to understand the mechanisms of KoRV oncogenesis, this study has 
provided evidence to suggest similar mechanisms are occurring in geographically separate 
koala populations where differences in koala genetics (Kjeldsen et al., 2016) and KoRV 
variants (Sarker et al., 2019b) appear to have little effect on lymphoma development.  
This study has provided further information on the pathogenesis of KoRV infection 
by comparing the aetiology, haematology and splenic lymphoid area of Qld and SA koalas. It 
is becoming more apparent that there are significant differences in KoRV infection between 
Qld and SA koalas, including prevalence, KoRV proviral load differences, range of KoRV 
variants and viral activity.  In Qld koalas, KoRV is an active endogenous virus, KoRV 
proviral and viral loads are high in all koalas and all koalas have many concurrent KoRV 
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variant infections, while in SA, proviral loads are lower, not all koalas had active KoRV 
infections and KoRV-A was the most prevalent variant. The reasons behind KoRV inactivity 
in SA koalas may be due to the immune response to exogenous infections or to a truncated 
KoRV, theories currently under investigation.  Despite these population differences, 
lymphoid neoplasia was found to develop in both northern and southern koalas with the same 
pathological features, which suggests the same basic KoRV-induced oncogenic pathway is 
occurring in both populations. Additionally, haematology and splenic investigations 
highlighted that in both northern and southern koalas, lymphocytes and lymphoid tissue may 
be key sites where KoRV replication occurs, and haematological changes in viraemic koalas 
may mirror those of regressive or progressive FeLV infection in cats.  Therefore, in SA 
koalas, high KoRV activity may be a useful prognostic indicator for the development of 
lymphoma and chlamydial disease. KoRV infection appears to be highly complex, therefore 
continued investigation is required to fully understand the pathogenesis of KoRV and 
implications of infection for koala health. 
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Table 1  
Summary of koalas from South Australia (n = 92) and Queensland (n = 67) for four 
pathological categories 
Category SA Wild Qld Wild* Qld Captive 
Neoplasia 5 9 0 
     Female 3 2 - 
     Male 2 7 - 
     Mean TWC (± SEM) 2.75 ± 0.85 4.22 ± 0.32 - 
     Mean BCS (± SEM) 3.00 ± 0.00 1.67 ± 0.24 - 
Chlamydial disease 33 31 0 
     Female 20 12 - 
     Male 13 19 - 
     Mean TWC (± SEM) 3.73 ± 0.21 4.74 ± 0.32 - 
     Mean BCS (± SEM) 3.13 ± 0.17 1.80 ± 0.14 - 
Miscellaneous disease 31 4 0 
     Female 12 2 - 
     Male 19 2 - 
     Mean TWC (± SEM) 3.07 ± 0.22 6.00 ± 1.00 - 
     Mean BCS (± SEM) 3.10 ± 0.18 1.00 ± 0.00 - 
Disease-free 23 2 21 
     Female 7 1 12 
     Male 16 1 9 
     Mean TWC (± SEM) 3.19 ± 0.25 4.00 ± 1.00 3.00 ± 0.40 
     Mean BCS (± SEM) 4.00 ± 0.22 4.00 ± 0.50 0.51 ± 0.11 
*Includes wild necropsied (n = 28) and wild, rescued (n = 18) koalas sampled 
during clinical examination 






Number of koalas observed with chlamydial disease at one or more sites from 
Queensland (n = 31) and South Australia (n = 33) 
 





Ocular disease only 10 (32.3) 1 (3.0) 
Respiratory disease only 0 (0) 1 (3.0) 
Urinary tract disease only 8 (25.8) 7 (21.2) 
Reproductive tract disease only† 1 (3.2) 9 (27.3) 
Disease at two or more sites 12 (38.7) 15 (45.5) 
*Not all tissues were examined histologically from all koalas 
†Reproductive tracts were not available for examination from all Qld koalas 








Summary of histopathological changes in koalas with chlamydial disease (PCR positive and negative for Chlamydia pecorum infection) 
from Queensland (n = 31) and South Australia (n = 33) submitted for necropsy examination* 
 
Site Queensland South Australia 
Ocular 18 (58.1%) (4 female, 14 male) 4 (12.1%) (1 female, 3 male) 
lesions† Grossly apparent lesions 
Grade 1 (n = 2) 
Grade 2 (n = 2) 
Bilateral conjunctivitis with corneal opacity 
Grade 3 (n = 7) 
Bilateral, chronic active conjunctivitis, with 
or without keratitis 
Not graded (n = 7) 
Grossly inapparent lesions 
Grade 1 (n = 1) 
Minimal to mild non-suppurative conjunctivitis 
Grossly apparent lesions 
Grade 2 (n = 1) 
Bilateral, minimal to mild non-suppurative conjunctivitis 
Grade 3 
Bilateral, mild to marked proliferative, chronic active mixed 
neutrophilic and lymphoplasmacytic conjunctivitis (n = 2) 
and mixed keratitis (n = 1) 
Urinary 19 (58.1%) (8 female, 11 male) 23 (69.7%) (10 female, 13 male) 
lesions Kidney (n = 2) 
Nephritis (n = 2) 
Chronic, non-suppurative or granulomatous, 
with fibrosis 
Bladder (n = 18) 
Grade 1 (n = 3) 
Grade 2 (n = 2) 
Superficial, mild to moderate, non-
suppurative cystitis 
Grade 3 (n = 7) 
Chronic, moderate, active mixed cystitis 
Kidney (n = 9) 
Interstitial fibrosis (n = 3) 
Nephritis 
Non-suppurative, mild to moderate (n = 4) 
Pyelonephritis (n = 2) 
Mild to moderate, lymphoplasmacytic, neutrophilic, or mixed, 
with segmental tubular degeneration, loss and fibrosis 
Bladder (n = 18) 
Grade 1 (n = 14) 
Superficial, mild to moderate, non-suppurative cystitis 
Grade 2 (n = 4) 
43 
 
Not graded (n = 6) 
 
Penile and/or prostatic urethra not examined 
Chronic, moderate, active lymphoplasmacytic or mixed cystitis, 
pericloacal urine staining 
 
Penile and/or prostatic urethritis (n = 10) 
Reproductive 4 (12.9%) (4 female) 23 (69.7%) (13 female, 10 male) 
female lesions† Ovary 
Paraovarian cyst (n = 3) 
 
Vagina 
Vaginitis (n = 1) 
 
Ovary 
Paraovarian cyst (n = 10) 
Hyperplastic, fibrocollagenous cyst, non-suppurative 
Uterus 
Mild, chronic, non-suppurative endometritis (n = 6) 
Mild to moderate, mixed, active endometritis (n = 2) 
Necrosuppurative endometritis (n = 1) 
Vagina 
Moderate to severe, non-suppurative ulcerative vaginitis (n = 1) 
Male lesions† Not examined Testis 
Mild interstitial fibrosis (n = 6) 
Sperm granuloma (n = 1) 
Epididymis 
Sperm granuloma (n = 2) 
Prostate 
Non-suppurative prostatitis (n = 1) 
Moderate to severe, chronic, active mixed periurethral or 
glandular prostatitis, may have microabscessation (n = 6) 
*Some koalas presented with disease at multiple sites 










Median number of lymphoid follicles and periarteriolar lymphoid sheaths and lymphoid area in spleen histological sections collected 
from necropsied koalas from South Australia and Queensland 
Category n = 
Median number of 
follicles (range) 
Median number of 
PALSs (range) 
Median follicle size 
(range) (µm2) 
Median PALS size 
(range) (µm2) 
Population       
   SA 31 0 (0–4) 3 (0–13) 6,955 (0–216,678) 71,754 (0–303,866) 
   Qld 10 1 (0–2) 4.5 (1–11) 46,365 (0–215,330) 108,408 (40,466–530,077) 
Disease category      
   Chlamydial 23 1 (0–3) 5 (1–13) 40,697 (0–215,330) 90,303 (18,201–530,077) 
   Miscellaneous 7 0 (0–3) 1 (0–3) 0 (0–157,264) 64,551 (0–210,788) 
   Disease-free 11 0 (0–4) 3 (0–6) 57,273 (0–216,678) 128,150 (303,866–127,920) 
Sex      
   Female 20 0.5 (0–2) 4 (1–11) 35,142 (0–215,330) 81,028 (18,202–230,588) 
   Male 21 1 (0–4) 3 (0–13) 23,027 (0–216,678) 97,050 (0–530,077) 
BCS      
   Excellent 12 1 (0–4) 2.5 (1–6) 90,935 (0–216,678) 121111 (42,242–303,866) 
   Fair 12 0 (0–2) 3 (0–6) 0 (0–76,960) 46,314 (0–210,788) 
   Poor 13 1 (0–2) 5 (1–11) 40,697 (0–215,330) 98,836 (40,466–530,077) 
Follicle numbers and area were compared by non-parametric Mann–Whitney test. Bold values indicate the variables are significantly 
different from each other (P <0.05). 








Median KoRV proviral and viral loads of koalas from Queensland and South Australia 
for four disease categories 
Category n 
Median proviral load (range) 
(copies KoRV DNA/103 β-actin 
copies) n 
Median viral load (range) 
(copies KoRV RNA/ml of 
plasma) 
Neoplasia     
    Qld 
9 
5.25 × 104 (3.38 × 104–4.78 × 
105) 
9 
3.15 × 109 (2.68 × 107–7.58 × 
1011) 
    SA 
5 
2.14 × 105 (6.71 × 103–4.32 × 
105) 
4 
5.26 × 109 (6.19 × 105–4.34 × 
1010) 
Chlamydial     
    Qld 
31 
5.83 × 104 (2.55 × 104–5.91 × 
105) 
30 
2.18 × 109 (2.16 × 107–1.06 × 
1011) 
    SA 
33 
4.26 × 103 (2.2 × 101–4.08 × 
104) 
8 
6.39 × 104 (2.28 × 104–1.38 × 
109) 
Miscellaneous     
    Qld 
4 
6.62 × 104 (2.67 × 103–7.88 × 
104) 
4 
4.12 × 107 (5.79 × 107–5.88 × 
1010) 
    SA 
31 
2.16 × 103 (1.1 × 101–1.82 × 
105) 
5 
2.55 × 105 (8.48 × 104–1.64 × 
109) 
Disease-free     
    Qld 
23 
4.46 × 104 (1.04 × 104–7.92 × 
104) 
23 
7.43 × 107 (7.76 × 106–6.59 × 
108) 
    SA 
23 
2.51 × 103 (2.5 × 101–5.05 × 
104) 
3 8.54 x 104 (4.38 x 104-1.85 x 105) 






Fig. 1. Lymphoma. Infiltration of the bladder mucosal layer in a 4-year-old (TWC III) male 
South Australian koala. (A) Bladder wall is thickened with irregular reddened and pale 
mucosal surface. Bar, 1 cm. (B) Lymphoma of the bladder mucosa and submucosa, with 
neoplastic infiltration and loss of normal architecture.  Note neoplastic cellular infiltration 
into muscularis (arrow). HE. Bar, 1 mm.  
 
Fig. 2. Lymphoma. Infiltration of the submandibular lymph node of a 1- to 2-year-old (TWC 
I) male South Australian koala.  (A) Scant T cells within the affected submandibular lymph 
node.  IHC.  Bar, 50 µm.  (B) Neoplastic B cells efface normal nodal architecture.  IHC.  Bar, 
50 µm. 
 
Fig. 3. Conjunctivitis. Grade 3 conjunctivitis of the left eye in a 2- to 3-year-old (TWC II) 
male koala from South Australia infected with Chlamydia pecorum. (A) Conjunctival 
hyperplasia and purulent exudate. Bar, 1 cm. (B) Marked proliferative chronic, active 
ulcerative neutrophilic, histiocytic and lymphoplasmacytic conjunctivitis. HE. Bar, 1 mm. 
 
Fig. 4. Urinary tract disease. Grade 2 urinary tract disease in a 5- to 6-year-old (TWC IV) 
male koala from South Australia infected with Chlamydia pecorum.  (A) Pericloacal urinary 
staining. Bar, 1 cm.  (B) Mild to moderate non-suppurative cystitis.  HE. Bar, 1 mm.  (C) 
Multifocal chronic active neutrophilic, histiocytic and lymphoplasmacytic interstitial 
pyelonephritis.  HE.  Bar, 50 µm. 
 
Fig. 5.  Comparison of mean ± SD haematological values of koalas between disease 





miscellaneous disease (n = 17; red diamond) and disease-free (n = 35; green triangle), 
compared with koala haematological reference intervals for northern (upper and lower 
intervals, broken lines) (Canfield et al., 1989b) and southern koalas (upper and lower 
intervals, solid lines) (Fabijan et al., 2020). 
 
Fig. 6.  Relationship of log transformed koala retrovirus (KoRV) proviral load (copies KoRV 
DNA/103 β-actin copies) and viral load (copies KoRV RNA/ml plasma) of Queensland (n = 
66) (open) and South Australian (n = 38) (solid) koalas from three distinct KoRV activity 
groups; high KoRV activity (log10 viral load >6.5, solid line), low KoRV activity (log10 viral 
load <6.5) and no KoRV activity (log10 viral load = 0). Disease categories of each koala are 
presented; neoplasia (circle), chlamydial disease (square), miscellaneous disease (diamond) 
and disease-free (triangle). 
 
